Decline depth
-43.6%
From rolling 252-day high of $18.31, 156d ago.
Past the 40% Red List threshold.
-43.6%
from rolling 252-day high of $18.31 set 2025-12-23 · 156d ago
Current
$10.32
Decline depth
-43.6%
Decline σ
5.7σ
TFC
4/5 bearish
Rolling 252-day high
Up day
Down day
Last 90 trading days · data from Alpaca
Since tracking began
$PHAT has been tracked since 2026-03-01. It was down 37.4% from its 52-week high then — now down -43.6%.
That's 4.1 percentage points deeper than the day it joined. It bottomed 49.5% below that high along the way.
Decline from the 52-week high as it stood on 2026-03-02 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.
Structural break signals
PHAT qualifies for the Red List on decline depth.
Time-frame continuity
4/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Past the 4/5 Amber threshold.
Decline sigma
5.7σ
Drop from local high over the last 10 bars, expressed in units of the stock's typical daily volatility (4.08% per day).
Past the ≥4σ Watch threshold.
The structural read
What price action says about PHAT.
PHAT qualifies for the Red List on decline depth — down -43.6% from its rolling 252-day high. Past the 40% threshold, the deepest tier in the taxonomy.
Cross-confirmation: also showing 4/5 bearish time frames.
Cross-confirmation: decline sigma also reads 5.7σ over 10 bars.
Earnings on file: 2026-04-30. Tiering is unaffected by earnings dates — listings reflect price structure only.
52-week range
52W low $3.10
47.5% of range
52W high $18.31
Sector context · Healthcare
194 other Healthcare tickers are on Broken Stocks.
88
Red List
47
Amber
59
Watch
-35.8%
Median decline
Worst in sector: OPRX (-77.1%). Least-bad: MRNA (-20.1%). See all Healthcare listings →
Related — same sector
Closest decliners to PHAT
Red List
TNDM
Tandem Diabetes Care, Inc.
Red ListRecovering
SMMT
Summit Therapeutics Inc.
Red List
ORIC
Oric Pharmaceuticals, Inc.
Red ListRecovering
SGRY
Surgery Partners, Inc.
Red ListRecovering
VTYX
Ventyx Biosciences, Inc.
Red List
OFIX
Orthofix Medical Inc.
Questions about PHAT
What people ask.
Why is PHAT on Broken Stocks?
PHAT qualifies for the Red List on decline depth. It is down -43.6% from its rolling 252-day high of $18.31, set on 2025-12-23 — 156d ago.
Is PHAT a falling knife?
Not by the strict technical definition. PHAT is down -43.6% from its 52-week high, but that high was set 156d ago — more than 120 days. A falling knife is usually a recent breakdown from a fresh high, not an established multi-quarter downtrend. PHAT is still on the Red List for decline depth, but the freshness component of a falling knife is missing.
Is PHAT a buy?
Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.
Where is PHAT trading inside its 52-week range?
At $10.32, PHAT sits 47.5% of the way from its 52-week low ($3.10) to its 52-week high ($18.31). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.
How fast has PHAT been declining?
The current 43.6% decline accrued over 156d, which annualizes to roughly -102.0% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.
How does PHAT compare to its sector?
There are 194 other Healthcare tickers on Broken Stocks: 88 Red, 47 Amber, 59 Watch, with 108 showing recovering structural signals. Median sector decline is -35.8% — PHAT's decline is deeper than the sector median.
Does PHAT's earnings date affect its tier?
No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-04-30) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.